Relevance of Medical Ethics in Public Health: Case Study of Polio Eradication

Author:

John T JacobORCID,Dharmapalan Dhanya

Abstract

Global Polio Eradication began in 1988, with a time target of 2000, but it remains unfinished in 2023. Since 2000, polio caused by vaccine-virus-turned wild-like has been paralyzing many children in several countries that still use the live attenuated oral polio vaccine (OPV), according to the policy of Global Polio Eradication Initiative (GPEI). We have detected a fundamental flaw in GPEI’s intervention tactics that began in 1988 with the exclusive use of OPV – which contravened the principles of medical ethics, namely beneficence, non-maleficence and justice – while a safe and highly efficacious alternative, the inactivated poliovirus vaccine (IPV), was already available. This flaw remained unrecognized as the common perception is that public health actions are ‘public good,’ hence outside the purview of medical ethics. We argue why medical ethics must apply to public health when a pharmaceutical substance is included in the intervention. Having identified unethical vaccine-choice as the root cause of both the failure to eradicate polio so far and causing widespread iatrogenic polio, it is imperative that the flawed policy is reversed at the earliest, for which we propose a way forward. We also advocate for financial compensation to be given to all individuals harmed by the unethical vaccine-policy of GPEI.

Publisher

Qeios Ltd

Reference56 articles.

1. Beauchamp EL, Childress JF. Principles of Biomedical Ethics. Second Edition. New York: Oxford University Press;1983.

2. Sampath R. When is iatrogenic harm negligent? AMA J Ethics 2022; 24(8): E735-739. DOI 10.1001/amajethics.2022.735.

3. American Medical Association. Council on Ethical and Judicial Affairs. Competence, self-assessment and self-awareness. Report 1-I-19. Available at https://www.ama-assn.org/system/files/2019-12/i19-ceja-report-1.pdf.

4. Twerski A, Cohen NB. Informed decision-making and the law of torts: the myth of justiciable causation. U Ill L Rev 1988; 607-665.

5. Idanpaan-Heikkila. WHO guidelines for good clinical practice (GCP) for trials in pharmaceutical products: responsibilities of the investigator. Ann Med 1994; 26(2):89-94. doi: 10.3109/07853899409147334

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3